Impact Factor
2.49
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.85
274 total citations
h5-index
23
h5 depth signal
Cited share
24.1%
78 of 324
Total citations
274
Citation footprint
Metric signal
2.25
External metric anchor
Self-citation
4.0%
11 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Germany
576
Switzerland
111
Austria
96
United States
67
Italy
42
Citing Fields of Research
Hematology
177
Cardiology
32
Clinical Laboratory Science
22
Immunology
15
Vascular Disorders
8
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,637
Articles tracked across the journal lifetime
Indexed publication set
324
78 cited publications
Last 12 months
249
24.9 publications/month
Open access share
5.6%
14 OA publications in the last year
Leading citing country
Germany
576 citing publications
Leading citing field
Hematology
177 citing publications
Latest tracked publication
7 October 2026
10 recent records available
Coverage & Indexing History
v22n1, Feb. 2002-
v22n1, Feb. 2002-
Active Coverage
Research Focus & Classification
Indexed Subjects
Hematology
Broad Categories
Hematology
MeSH Descriptors
Hemostasis
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1055/a-2957-0168
Open DOI
Hemostatic Considerations of New Treatment Options for Hemophilia During Surgery, Infection, and Bleeding in Children and Adolescents
In recent years, the therapeutic landscape for hemophilia has changed significantly, with the approval of several innovative agents, some featuring entirely novel mechanisms of action. These advances have substantially improved outcomes ...
02
DOI 10.1055/a-2940-6179
Open DOI
Platelet Type Von Willebrand Disease – Diagnostic and Therapeutic Challenges
Platelet-type von Willebrand disease (PT-VWD) is a rare thrombocytopathy caused by gain-of-function variants in GP1BA, leading to increased binding of von Willebrand factor (VWF). Because its phenotype closely resembles VWD type 2B (VWD ...
03
DOI 10.1055/a-2926-8391
Open DOI
Diagnosing Immune Thrombocytopenia: An Update
Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by increased platelet destruction and impaired platelet production, resulting in isolated thrombocytopenia. Despite advances in understanding disease pathophy...
04
DOI 10.1055/a-2937-0837
Open DOI
A novel Mutation p.Thr308Asn in the Snout-like Region of the Fibrinogen Bβ Chain: Analysis of the Pathogenic Mechanism of Hereditary Hypofibrinogenemia
Background Fibrinogen, encoded by FGA, FGB, and FGG, is essential for blood coagulation. Mutations in these genes cause congenital fibrinogen disorders, leading to bleeding and thrombotic complications. The Bβ chain is the rate-limiting ...
05
06
07
DOI 10.1055/a-2822-5925
Open DOI
Standards and Practice in Haemostasis
08
09
10
DOI 10.1055/a-2822-6063
Open DOI
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert
Bibliographical & Catalog Notes
Also issued online.
Text in German; table of contents in English and German.